Accenture CEO diagnosed with breast cancer

Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health events
Diane Brady on how CEOs should handle a cancer diagnosis. The big story: Reciprocal trade tariffs. The markets: Approaching all-time highs, again. Analyst notes from JP Morgan, Goldman Sachs, Wedbush.
Accenture CEO Julie Sweet diagnosed with early-stage breast cancer, treatment likely to last 12-16 weeks
Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.
Accenture CEO Julie Sweet diagnosed with cancer, to undergo surgery next week
Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable condition, she will undergo surgery and radiation treatment while continuing her leadership role with reduced travel.
Accenture CEO diagnosed with breast cancer, to undergo surgery next week
However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the treatment.
Accenture CEO’s Cancer Diagnosis Gives Insight Into How Execs Divulge Illness
Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare insight into how executives disclose their life-altering health news. Sweet,
Accenture CEO Julie Sweet shares health update
Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer. In a message to all Accenture employees,
Meet CEO of one of world's biggest IT firms, who will undergo treatment for breast cancer
Julie Sweet, Chief Executive Officer of Accenture has recently been diagnosed with early-stage breast cancer and will undergo the treatment for about 12-16 weeks.
CRN5y
Accenture Names Julie Sweet CEO
Sweet has been CEO ... forward to working closely with Julie as chief executive officer.” Nanterme, who had been CEO since 2011, was diagnosed with colon cancer in July 2016 and underwent ...